Hepatic arterial infusion chemotherapy (HAIC) combined with regorafenib and PD-1 inhibitors in the treatment of liver metastases of colorectal cancer after failure of second-line chemotherapy: a single-arm prospective, open-label phase II clinical trial
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/41970
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Experimental group:Hepatic arterial infusion chemotherapy;Experimental group:Regorafenib;Experimental group:Intravenous infusion PD-1 inhibitors
Primary outcome(s): Objective Response Rate (ORR)
Study Design: Single arm
创建时间：
2022-09-15
